AMPH

Amphastar Pharmaceuticals, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$28.87

Price (1 Year)

$29.26 $16.87

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %37.7 / %30
Non-compliant assets / Total market cap %1.8 / %30
Non-compliant revenue / Total income %1.2 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose.

Website

Analysis (Turkish): AMPH Hissesi Caiz mi, Helal mi? Amphastar Pharmaceuticals, Inc. Katılım Analizi